Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
8.91
-0.64 (-6.70%)
Aug 24, 2026, 9:35 AM EDT - Market open
Absci Market Cap
Absci has a market cap or net worth of $1.53 billion as of August 24, 2026. Its market cap has increased by 288.84% in one year.
Market Cap
1.53B
Enterprise Value
1.33B
1-Year Change
288.84%
Ranking
Category
Stock Price
$8.91
ChartMarket Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $1.53B, an increase of 261.32%. That is a compound annual growth rate of 28.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 1.53B | 191.37% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 1.75B |
| AnaptysBio | 1.71B |
| Avalyn Pharma | 1.70B |
| Vir Biotechnology | 1.65B |
| Maze Therapeutics | 1.63B |
| Bicara Therapeutics | 1.58B |
| Tyra Biosciences | 1.55B |
| Apnimed | 1.55B |